Pfizer
Search results
3 days ago · Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
Apr 30, 2024 · INDIANAPOLIS, April 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first quarter of 2024. "Lilly's first quarter performance reflects solid year-over-year revenue growth with strong sales of Mounjaro and Zepbound," said David A. Ricks, Lilly's chair and CEO. "Our progress in addressing ...
5 days ago · Eli Lilly and Company was established in May 1876 in Indianapolis, Indiana by Eli Lilly, a pharmaceutical chemist who served as a colonel in the Union Army during the U.S. Civil War. His previous ventures included a drug store in Paris, Illinois and a drug-manufacturing enterprise in Indianapolis called Johnston and Lilly, which was dissolved ...
Apr 30, 2024 · INDIANAPOLIS , May 6, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. The dividend is payable on June 10, 2024, to shareholders of record at the close of. Revenue in Q1 2024 increased 26%, driven by Mounjaro ...
Apr 22, 2024 · Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce the latest life-changing medicines. INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical ...
People also ask
Where is Eli Lilly based?
Who was Eli Lilly and what did he do?
Why did Eli Lilly reorganize?
How many employees does Eli Lilly have?
3 days ago · The U.S. Food and Drug Administration (FDA) will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) on Monday, June 10, 2024, to discuss donanemab, which Eli Lilly and Company (NYSE: LLY) has submitted for the treatment of early symptomatic Alzheimer’s disease. The open public hearing ...
Apr 30, 2024 · On April 30, 2024, Eli Lilly and Co announced its first-quarter financial results for 2024, revealing a significant increase in revenue and earnings per share (EPS), exceeding analyst expectations.
